It is a challenge as old as lawmaking: how do legislators write rules today that can keep pace with the innovations of tomorrow? The problem is particularly acute in fast-moving sectors where scientific advances arrive at breakneck speed. Artificial intelligence (AI) and big data, wearables and genomics — these are among the most disruptive and…

Today, European institutions are leading the biggest legislative revision of the EU’s pharmaceutical framework we have ever seen[1]. A revision that is needed after more than 20 years. Reflecting on this legislative review, I believe all stakeholders involved and affected by this revision should ask the following question; how can we work together with all…

“What we need around here is more creativity.” Those eight words – one mighty concept leading to one daunting challenge – were spoken in 1997 by a client of mine, the CEO of a private investment firm, in his Wall Street office. Little did he know that his entreaty would ignite a spark in me:…

Editor’s note: In today’s printing industry, the concept of innovation is wide in definition, but rather narrow in its goal. Leading companies grasp many tools to define themselves, increase profitability, and differentiate themselves. They utilize new technologies, systems integration, novel human resources practices, diversification, exemplary customer services, and so much more. The six companies included…

The research team’s findings are recorded in the forthcoming article “Are public health policies associated with corporate innovation? Evidence from U.S. nonsmoking laws” in the December issue of Research Policy.  Local laws proved to be the most effective at addressing smoking in the workplace, as they were more likely to be enforced compared to wider…

By Barry Davidson While there are an increasing number of companies leveraging the capabilities of artificial intelligence (AI) in the pharmaceutical industry (Box 1), there are relatively few operations dedicated exclusively to biopharmaceutical protein discovery and development. One of those companies is BigHat Biosciences, based in San Mateo, California. “Our vision was to build, from…

By Barry Davidson While there are an increasing number of companies leveraging the capabilities of artificial intelligence (AI) in the pharmaceutical industry (Box 1), there are relatively few operations dedicated exclusively to biopharmaceutical protein discovery and development. One of those companies is BigHat Biosciences, based in San Mateo, California. “Our vision was to build, from…

Tulane’s new Faculty Innovation Council, spearheaded by the Tulane University Innovation Institute (TUII), is chaired by Tony Hu, Weatherhead Presidential Chair in Biotechnology Innovation and director of the Center for Cellular and Molecular Diagnostics, and Kimberly Gramm, the David and Marion Mussafer Chief Innovation and Entrepreneurship Officer at TUII. Tulane faculty now have a direct…

Innovation and emerging technologies get top billing as U.S., Australia reaffirm tech-focused alliance | FedScoop Skip to main content Advertisement Advertisement Close The initiatives include efforts to establish a framework for space-related actions, support Pacific Island nations’ digital connectivity and fund the Net Zero Technology Acceleration Partnership. WASHINGTON, DC – OCTOBER 25: U.S. President Joe…